#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Hypoxia Induces an Immunodominant Target of Tuberculosis Specific T Cells Absent from Common BCG Vaccines


M.
tuberculosis
(MTB) species-specific antigenic determinants of the human T cell response are important for immunodiagnosis and vaccination. As hypoxia is a stimulus in chronic tuberculosis infection, we analyzed transcriptional profiles of MTB subject to 168 hours of hypoxia to test the hypothesis that upregulation by hypoxia might result in gene products being recognized as antigens. We identified upregulation of two region of difference (RD) 11 (Rv2658C and Rv2659c), and one RD2 (Rv1986) absent from commonly used BCG strains. In MTB infected persons, the IL-2 ELISpot response to Rv1986 peptides was several times greater than the corresponding IFN-γ response to the reference immunodominant ESAT-6 or CFP-10 antigens. The IL-2 response was confined to two epitopic regions containing residues 61–80 and 161–180. The biggest population of IL-2 secreting T cells was single cytokine positive central memory T cells. The IL-2 response to live MTB bacilli lacking Rv1986 was significantly lower than the response to wild type or mutant complemented with Rv1986. In addition, the IL-2 response to Rv1986 was significantly lower in HIV-TB co-infected persons than in HIV uninfected persons, and significantly increased during antiretroviral therapy. These findings demonstrate that Rv1986 is an immunodominant target of memory T cells and is therefore of relevance when considering the partial efficacy of currently used BCG vaccines and provide evidence for a clinical trial comparing BCG strains.


Vyšlo v časopise: Hypoxia Induces an Immunodominant Target of Tuberculosis Specific T Cells Absent from Common BCG Vaccines. PLoS Pathog 6(12): e32767. doi:10.1371/journal.ppat.1001237
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1001237

Souhrn

M.
tuberculosis
(MTB) species-specific antigenic determinants of the human T cell response are important for immunodiagnosis and vaccination. As hypoxia is a stimulus in chronic tuberculosis infection, we analyzed transcriptional profiles of MTB subject to 168 hours of hypoxia to test the hypothesis that upregulation by hypoxia might result in gene products being recognized as antigens. We identified upregulation of two region of difference (RD) 11 (Rv2658C and Rv2659c), and one RD2 (Rv1986) absent from commonly used BCG strains. In MTB infected persons, the IL-2 ELISpot response to Rv1986 peptides was several times greater than the corresponding IFN-γ response to the reference immunodominant ESAT-6 or CFP-10 antigens. The IL-2 response was confined to two epitopic regions containing residues 61–80 and 161–180. The biggest population of IL-2 secreting T cells was single cytokine positive central memory T cells. The IL-2 response to live MTB bacilli lacking Rv1986 was significantly lower than the response to wild type or mutant complemented with Rv1986. In addition, the IL-2 response to Rv1986 was significantly lower in HIV-TB co-infected persons than in HIV uninfected persons, and significantly increased during antiretroviral therapy. These findings demonstrate that Rv1986 is an immunodominant target of memory T cells and is therefore of relevance when considering the partial efficacy of currently used BCG vaccines and provide evidence for a clinical trial comparing BCG strains.


Zdroje

1. WHO 2008 Global tuberculosis control - surveillance, planning, financing. Geneva WHO

2. MaartensG

WilkinsonRJ

2007 Tuberculosis. Lancet 370 2030 2043

3. MahairasGG

SaboPJ

HickeyMJ

SinghDC

StoverCK

1996 Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol 178 1274 1282

4. PymAS

BrodinP

BroschR

HuerreM

ColeST

2002 Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46 709 717

5. BerthetFX

RasmussenPB

RosenkrandsI

AndersenP

GicquelB

1998 A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology 144 3195 3203

6. SorensenAL

NagaiS

HouenG

AndersenP

AndersenAB

1995 Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 63 1710 1717

7. PymAS

BrodinP

MajlessiL

BroschR

DemangelC

2003 Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9 533 539

8. PaiM

ZwerlingA

MenziesD

2008 Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149 177 184

9. ColeS

BroschR

ParkhillJ

GarnierT

ChurcherC

1998 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 537 544

10. BehrMA

WilsonMA

GillWP

SalamonH

SchoolnikGK

1999 Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284 1520 1523

11. BroschR

GordonSV

GarnierT

EiglmeierK

FriguiW

2007 Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci U S A 104 5596 5601

12. BehrMA

SmallPM

1997 Has BCG attenuated to impotence? Nature 389 133 134

13. DavidsV

HanekomWA

MansoorN

GamieldienH

GelderbloemSJ

2006 The effect of Bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 193 531 536

14. SiddersB

PirsonC

HogarthPJ

HewinsonRG

StokerNG

2008 Screening of highly expressed mycobacterial genes identifies Rv3615c as a useful differential diagnostic antigen for the Mycobacterium tuberculosis complex. Infect Immun 76 3932 3939

15. ShermanDR

VoskuilM

SchnappingerD

LiaoR

HarrellMI

2001 Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A 98 7534 7539

16. NicholsonS

Bonecini-AlmeidaMdG

Lapa e SilvaJR

NathanC

XieQ-W

1996 Inducible Nitric Oxide Synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 183 2293 2302

17. MacMickingJD

NorthRJ

LaCourseR

MudgettJS

ShahSK

1997 Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94 5243 5248

18. ViaLE

LinPL

RaySM

CarrilloJ

AllenSS

2008 Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76 2333 2340

19. WilkinsonRJ

WilkinsonKA

De SmetKAL

HaslovK

PasvolG

1998 Human T and B cell reactivity to the 16 kDa alpha crystallin protein of Mycobacterium tuberculosis. Scand J Immunol 48 403 409

20. LeytenEM

LinMY

FrankenKL

FriggenAH

PrinsC

2006 Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect 8 2052 2060

21. GelukA

LinMY

van MeijgaardenKE

LeytenEM

FrankenKL

2007 T cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not BCG vaccination. Infect Immun 75 2914 2921

22. WilkinsonKA

StewartGR

NewtonSM

VordermeierHM

WainJR

2005 Infection Biology of a Novel alpha-Crystallin of Mycobacterium tuberculosis: Acr2. J Immunol 174 4237 4243

23. SchuckSD

MuellerH

KunitzF

NeherA

HoffmannH

2009 Identification of T-cell antigens specific for latent Mycobacterium tuberculosis infection. PLoS ONE 4 e5590

24. BlackGF

ThielBA

OtaMO

ParidaSK

AdegbolaR

2009 Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 16 1203 1212

25. RustadTR

HarrellMI

LiaoR

ShermanDR

2008 The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE 3 e1502

26. LalvaniA

NagvenkarP

UdwadiaZ

PathanAA

WilkinsonKA

2001 Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183 469 477

27. PathanAA

WilkinsonKA

KlenermanP

McShaneH

DavidsonRN

2001 Direct Ex Vivo Analysis of Antigen-Specific IFN-gamma-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment. J Immunol 167 5217 5225

28. SoaresAP

ScribaTJ

JosephS

HarbacheuskiR

MurrayRA

2008 Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J Immunol 180 3569 3577

29. WilkinsonKA

SeldonR

MeintjesG

RangakaMX

HanekomWA

2009 Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. Am J Respir Crit Care Med 180 674 683

30. GordonSV

EiglmeierK

GarnierT

BroschR

ParkhillJ

2001 Genomics of Mycobacterium bovis. Tuberculosis (Edinb) 81 157 163

31. BroschR

GordonSV

MarmiesseM

BrodinP

BuchrieserC

2002 A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99 3684 3689

32. CapuanoSV3rd

CroixDA

PawarS

ZinovikA

MyersA

2003 Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71 5831 5844

33. KaplanG

PostFA

MoreiraAL

WainwrightH

KreiswirthBN

2003 Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 71 7099 7108

34. LinPL

PawarS

MyersA

PeguA

FuhrmanC

2006 Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 74 3790 3803

35. TimmJ

PostFA

BekkerLG

WaltherGB

WainwrightHC

2003 Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc Natl Acad Sci U S A 100 14321 14326

36. UlrichsT

KosmiadiGA

JorgS

PradlL

TitukhinaM

2005 Differential Organization of the Local Immune Response in Patients with Active Cavitary Tuberculosis or with Nonprogressive Tuberculoma. J Infect Dis 192 89 97

37. YoungDB

GideonHP

WilkinsonRJ

2009 Eliminating latent tuberculosis. Trends Microbiol 17 183 188

38. BarryCE3rd

BoshoffHI

DartoisV

DickT

EhrtS

2009 The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7 845 855

39. StewartGR

NewtonSM

WilkinsonKA

HumphreysIR

MurphyHN

2005 The stress-responsive chaperone alpha-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis. Mol Microbiol 55 1127 1137

40. ShiL

JungYJ

TyagiS

GennaroML

NorthRJ

2003 Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci U S A 100 241 246

41. MillingtonKA

InnesJA

HackforthS

HinksTS

DeeksJJ

2007 Dynamic Relationship between IFN-gamma and IL-2 Profile of Mycobacterium tuberculosis-Specific T Cells and Antigen Load. J Immunol 178 5217 5226

42. RangakaMX

DiwakarL

SeldonR

van CutsemG

MeintjesGA

2007 Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis 44 1639 1646

43. OniT

PatelJ

GideonHP

SeldonR

WoodK

2010 Enhanced diagnosis of HIV-1 associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J epub 2010/01/ 16

44. VordermeierHM

ChambersMA

CocklePJ

WhelanAO

SimmonsJ

2002 Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70 3026 3032

45. RangakaMX

WilkinsonKA

SeldonR

Van CutsemG

MeintjesGA

2007 Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection. Am J Respir Crit Care Med 175 514 520

46. BoshoffHI

MyersTG

CoppBR

McNeilMR

WilsonMA

2004 The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279 40174 40184

47. HanekomWA

DockrellHM

OttenhoffTH

DohertyTM

FletcherH

2008 Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations. PLoS Med 5 e145

48. HawkridgeT

ScribaTJ

GelderbloemS

SmitE

TamerisM

2008 Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa. J Infect Dis 198 544 552

49. BeveridgeNE

PriceDA

CasazzaJP

PathanAA

SanderCR

2007 Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations. Eur J Immunol 37 3089 3100

50. ScribaTJ

TamerisM

MansoorN

SmitE

van der MerweL

2010 Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells. Eur J Immunol 40 279 290

51. SutherlandJS

AdetifaIM

HillPC

AdegbolaRA

OtaMO

2009 Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39 723 729

52. HsiehCS

MacatoniaSE

TrippCS

WolfSF

O'GarraA

1993 Development of TH1 CD4+ T cells through IL-12 produced by Listeria- induced macrophages. Science 260 547 549

53. McKnightAJ

PerezVL

SheaCM

GrayGS

AbbasAK

1994 Costimulator dependence of lymphokine secretion by naive and activated CD4+ T lymphocytes from TCR transgenic mice. J Immunol 152 5220 5225

54. MurrayJS

PfeifferC

MadriJ

BottomlyK

1992 Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype. Eur J Immunol 22 559 565

55. AgrewalaJN

WilkinsonRJ

1999 Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa alpha-crystallin antigen of Mycobacterium tuberculosis. Eur J Immunol 29 1753 1761

56. SinghH

RaghavaGP

2001 ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 1236 1237

57. CocklePJ

GordonSV

LalvaniA

BuddleBM

HewinsonRG

2002 Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect Immun 70 6996 7003

58. KalraM

KhullerGK

GroverA

BeheraD

WanchuA

2010 Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis. Diagn Microbiol Infect Dis 66 153 161

59. ChenJ

SuX

ZhangY

WangS

ShaoL

2009 Novel recombinant RD2- and RD11-encoded Mycobacterium tuberculosis antigens are potential candidates for diagnosis of tuberculosis infections in BCG-vaccinated individuals. Microbes Infect 11 876 885

60. FuR

WangC

ShiC

LuM

FangZ

2009 An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein. Clin Vaccine Immunol 16 686 691

61. GroverA

AhmedMF

VermaI

SharmaP

KhullerGK

2006 Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model. Protein Expr Purif 48 274 280

62. TrunzBB

FineP

DyeC

2006 Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367 1173 1180

63. BloomBR

FinePEM

1994 The BCG experience: Implications for future vaccines against tuberculosis.

BloomBR

Tuberculosis: Pathogenesis, protection and control Washington DC American Society for Microbiology 531 557

64. Henao-TamayoMI

OrdwayDJ

IrwinSM

ShangS

ShanleyC

2010 Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis. Clin Vaccine Immunol 17 618 625

65. HorwitzMA

HarthG

DillonBJ

Maslesa-GalicS

2009 Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis. Vaccine 27 441 445

66. WilkinsonKA

KonOM

NewtonSM

MeintjesG

DavidsonRN

2006 Effect of Treatment of Latent Tuberculosis Infection on the T Cell Response to Mycobacterium tuberculosis Antigens. J Infect Dis 193 354 359

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#